Genelux Corporation Common Stock

GNLX US36870H1032

💰
Capitalization
Small-cap

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

🔗
Website
https://www.genelux.com
Annual Performance 1
2023 2024 2025
128% -84% 5%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
56
🙍
Insiders
10
Person Price Shares Total Published Completed
Zindrick Thomas
CEO 		2.92
USD 		10,764
Sold 		31,431
USD 		12/05/2025 12/05/2025
Smalling Ralph
SR OFF 		2.92
USD 		1,259
Sold 		3,676
USD 		12/05/2025 12/05/2025
Ryder Sean
SR OFF 		2.92
USD 		4,475
Sold 		13,067
USD 		12/05/2025 12/05/2025
Smalling Ralph
SR OFF 		2.92
USD 		1,259
Sold 		3,676
USD 		12/05/2025 12/05/2025
Cappello Joseph
VP 		2.92
USD 		4,737
Sold 		13,832
USD 		12/05/2025 12/05/2025
Yu Yong
VP 		2.92
USD 		5,579
Sold 		16,291
USD 		12/05/2025 12/05/2025
Zindrick Thomas
CEO 		2.92
USD 		10,764
Sold 		31,431
USD 		12/05/2025 12/05/2025
Ryder Sean
SR OFF 		2.92
USD 		4,475
Sold 		13,067
USD 		12/05/2025 12/05/2025
Yu Yong
VP 		2.92
USD 		5,579
Sold 		16,291
USD 		12/05/2025 12/05/2025
Cappello Joseph
VP 		2.92
USD 		4,737
Sold 		13,832
USD 		12/05/2025 12/05/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Genelux Corporation Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-0% 30% -59% -92% 0% 0% -59%
Last 52W Low 52W High All-Time Low All-Time High β
4.71 2.08 4.71 2.08 4.71
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Szalay Aladar 26 3,133,077.40 120,502.98 23/10/2023 13/09/2024
Yu Yong 10 1,412,613.77 141,261.38 24/10/2023 12/05/2025
Tyree James L 4 131,979.48 32,994.87 13/12/2023 30/12/2024
Thomas John 2 120,386.89 60,193.44 13/12/2023 13/12/2023
Zindrick Thomas 3 96,358.86 32,119.62 16/12/2024 12/05/2025
Cappello Joseph 3 42,406.08 14,135.36 16/12/2024 12/05/2025
Ryder Sean 3 37,785.52 12,595.17 24/06/2024 12/05/2025
Smalling Ralph 3 13,225.96 4,408.65 16/12/2024 12/05/2025
Jewett Caroline 1 10,517.32 10,517.32 24/06/2024 24/06/2024
Zak Lourie S. 1 4,921.02 4,921.02 16/12/2024 16/12/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.